FDA rebuffs allegations that it has deprioritized enforcement

FDA is pushing back against assertions made in Science that a decline in the overall number of warning letters during the Trump administration is the result of a politically motivated, deregulatory agenda.

The article states that FDA’s "compliance and enforcement actions have plummeted since President Donald Trump took office.” It reports that the number of warning letters sent by FDA

Read the full 591 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers